Related Experiment Video
Updated: Jun 24, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Computer assessment of mild cognitive impairment
Judith Saxton1, Lisa Morrow, Amy Eschman
1Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA. saxtonja@upmc.edu
Postgraduate Medicine
|April 1, 2009
Summary
The Computer Assessment of Mild Cognitive Impairment (CAMCI) effectively identifies mild cognitive impairment in older adults. This user-friendly computer test shows high sensitivity and specificity, outperforming the Mini Mental State Examination (MMSE).
Area of Science:
- Gerontology
- Neuroscience
- Cognitive Health
Background:
- Cognitive decline is common in older adults, impacting daily function and quality of life.
- Mild cognitive impairment (MCI) affects medication adherence, decision-making, and independence.
- Current screening for cognitive difficulties by primary care physicians is not routine, and patients often underreport concerns.
Purpose of the Study:
- To compare the diagnostic accuracy of the Computer Assessment of Mild Cognitive Impairment (CAMCI) and the Mini Mental State Examination (MMSE) for identifying MCI.
- To evaluate the sensitivity and specificity of CAMCI in detecting mild cognitive impairment in elderly individuals.
Main Methods:
- A study involving 524 nondemented individuals over 60 years old.
- Participants completed a comprehensive neuropsychological and clinical assessment, alongside the CAMCI and MMSE.
- The CAMCI is a self-administered, user-friendly computer-based test.
Main Results:
- The Mini Mental State Examination (MMSE) demonstrated low sensitivity in identifying MCI.
- The Computer Assessment of Mild Cognitive Impairment (CAMCI) achieved high sensitivity (86%) and specificity (94%) for MCI detection.
- CAMCI proved superior to MMSE in identifying mild cognitive impairment in this cohort.
Conclusions:
- The CAMCI is a highly sensitive and specific tool for identifying mild cognitive impairment in community-dwelling, nondemented elderly individuals.
- CAMCI offers a promising solution for early detection of cognitive decline in primary care settings.
- Earlier identification via tools like CAMCI can facilitate timely diagnostic work-up and treatment initiation.
More Related Videos
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...